These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 31340061

  • 21. Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
    Lee JS, Rhee TM, Pietrasz D, Bachet JB, Laurent-Puig P, Kong SY, Takai E, Yachida S, Shibata T, Lee JW, Park HC, Zang DY, Jeon K, Lee J, Kim M, Kim HS, Kang HJ, Lee YK.
    Sci Rep; 2019 Nov 18; 9(1):16971. PubMed ID: 31740696
    [Abstract] [Full Text] [Related]

  • 22. Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA.
    Benešová L, Hálková T, Ptáčková R, Semyakina A, Menclová K, Pudil J, Ryska M, Levý M, Šimša J, Pazdírek F, Hoch J, Blaha M, Minárik M.
    World J Gastroenterol; 2019 Dec 28; 25(48):6939-6948. PubMed ID: 31908397
    [Abstract] [Full Text] [Related]

  • 23. Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.
    Watanabe F, Suzuki K, Tamaki S, Abe I, Endo Y, Takayama Y, Ishikawa H, Kakizawa N, Saito M, Futsuhara K, Noda H, Konishi F, Rikiyama T.
    PLoS One; 2019 Dec 28; 14(12):e0227366. PubMed ID: 31891652
    [Abstract] [Full Text] [Related]

  • 24. Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer.
    Groot VP, Mosier S, Javed AA, Teinor JA, Gemenetzis G, Ding D, Haley LM, Yu J, Burkhart RA, Hasanain A, Debeljak M, Kamiyama H, Narang A, Laheru DA, Zheng L, Lin MT, Gocke CD, Fishman EK, Hruban RH, Goggins MG, Molenaar IQ, Cameron JL, Weiss MJ, Velculescu VE, He J, Wolfgang CL, Eshleman JR.
    Clin Cancer Res; 2019 Aug 15; 25(16):4973-4984. PubMed ID: 31142500
    [Abstract] [Full Text] [Related]

  • 25. Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.
    Hadano N, Murakami Y, Uemura K, Hashimoto Y, Kondo N, Nakagawa N, Sueda T, Hiyama E.
    Br J Cancer; 2016 Jun 28; 115(1):59-65. PubMed ID: 27280632
    [Abstract] [Full Text] [Related]

  • 26. Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma.
    Labiano I, Huerta AE, Alsina M, Arasanz H, Castro N, Mendaza S, Lecumberri A, Gonzalez-Borja I, Guerrero-Setas D, Patiño-Garcia A, Alkorta-Aranburu G, Hernández-Garcia I, Arrazubi V, Mata E, Gomez D, Viudez A, Vera R.
    Sci Rep; 2024 Jul 13; 14(1):16203. PubMed ID: 39003322
    [Abstract] [Full Text] [Related]

  • 27. Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis.
    Yin L, Pu N, Thompson E, Miao Y, Wolfgang C, Yu J.
    Clin Cancer Res; 2021 Feb 01; 27(3):740-748. PubMed ID: 33082211
    [Abstract] [Full Text] [Related]

  • 28. Circulating tumor DNA correlates with tumor burden and predicts outcome in pancreatic cancer irrespective of tumor stage.
    Kirchweger P, Kupferthaler A, Burghofer J, Webersinke G, Jukic E, Schwendinger S, Weitzendorfer M, Petzer A, Függer R, Rumpold H, Wundsam H.
    Eur J Surg Oncol; 2022 May 01; 48(5):1046-1053. PubMed ID: 34876329
    [Abstract] [Full Text] [Related]

  • 29. Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic Adenocarcinoma.
    Bachet JB, Blons H, Hammel P, Hariry IE, Portales F, Mineur L, Metges JP, Mulot C, Bourreau C, Cain J, Cros J, Laurent-Puig P.
    Clin Cancer Res; 2020 Oct 01; 26(19):5208-5216. PubMed ID: 32605910
    [Abstract] [Full Text] [Related]

  • 30. Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review.
    Abdallah R, Taly V, Zhao S, Pietrasz D, Bachet JB, Basile D, Mas L, Zaanan A, Laurent-Puig P, Taieb J.
    Cancer Treat Rev; 2020 Jul 01; 87():102028. PubMed ID: 32485509
    [Abstract] [Full Text] [Related]

  • 31. Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy.
    Sugimori M, Sugimori K, Tsuchiya H, Suzuki Y, Tsuyuki S, Kaneta Y, Hirotani A, Sanga K, Tozuka Y, Komiyama S, Sato T, Tezuka S, Goda Y, Irie K, Miwa H, Miura Y, Ishii T, Kaneko T, Nagahama M, Shibata W, Nozaki A, Maeda S.
    Cancer Sci; 2020 Jan 01; 111(1):266-278. PubMed ID: 31746520
    [Abstract] [Full Text] [Related]

  • 32. Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.
    Maron SB, Chase LM, Lomnicki S, Kochanny S, Moore KL, Joshi SS, Landron S, Johnson J, Kiedrowski LA, Nagy RJ, Lanman RB, Kim ST, Lee J, Catenacci DVT.
    Clin Cancer Res; 2019 Dec 01; 25(23):7098-7112. PubMed ID: 31427281
    [Abstract] [Full Text] [Related]

  • 33. Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival.
    Baumgartner JM, Raymond VM, Lanman RB, Tran L, Kelly KJ, Lowy AM, Kurzrock R.
    Ann Surg Oncol; 2018 Aug 01; 25(8):2400-2408. PubMed ID: 29948422
    [Abstract] [Full Text] [Related]

  • 34. Circulating tumor DNA sequencing for colorectal cancers: A comparative analysis of colon cancer and rectal cancer data.
    Huang K, Qu H, Zhang X, Huang T, Sun X, He W, Li M, Lin L, Xu M, Chen S, Xia L.
    Cancer Biomark; 2019 Aug 01; 26(3):313-322. PubMed ID: 31561327
    [Abstract] [Full Text] [Related]

  • 35. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM, Ankeny JS, Sho S, Winograd P, Hou S, Song M, Wainberg ZA, Girgis MD, Graeber TG, Agopian VG, Tseng HR, Tomlinson JS.
    Ann Surg Oncol; 2018 Apr 01; 25(4):1000-1008. PubMed ID: 29442211
    [Abstract] [Full Text] [Related]

  • 36. Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations.
    Theparee T, Akroush M, Sabatini LM, Wang V, Mangold KA, Joseph N, Stocker SJ, Freedman A, Helseth DL, Talamonti MS, Kaul KL.
    Sci Rep; 2024 Jul 08; 14(1):15744. PubMed ID: 38977725
    [Abstract] [Full Text] [Related]

  • 37. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
    Fang Z, Meng Q, Zhang B, Shi S, Liu J, Liang C, Hua J, Yu X, Xu J, Wang W.
    Aging (Albany NY); 2020 Dec 09; 13(2):2031-2048. PubMed ID: 33318293
    [Abstract] [Full Text] [Related]

  • 38. Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.
    Narayan RR, Goldman DA, Gonen M, Reichel J, Huberman KH, Raj S, Viale A, Kemeny NE, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Jarnagin WR, Kingham TP.
    Ann Surg Oncol; 2019 Jun 09; 26(6):1824-1832. PubMed ID: 30706231
    [Abstract] [Full Text] [Related]

  • 39. Clinical value of sequential circulating tumor DNA analysis using next-generation sequencing and epigenetic modifications for guiding thermal ablation for colorectal cancer metastases: a prospective study.
    Boeken T, Pellerin O, Bourreau C, Palle J, Gallois C, Zaanan A, Taieb J, Lahlou W, Di Gaeta A, Al Ahmar M, Guerra X, Dean C, Laurent Puig P, Sapoval M, Pereira H, Blons H.
    Radiol Med; 2024 Oct 09; 129(10):1530-1542. PubMed ID: 39183242
    [Abstract] [Full Text] [Related]

  • 40. Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial.
    Tang C, Lee WC, Reuben A, Chang L, Tran H, Little L, Gumbs C, Wargo J, Futreal A, Liao Z, Xia X, Yi X, Swisher SG, Heymach JV, Gomez D, Zhang J.
    Int J Radiat Oncol Biol Phys; 2020 Feb 01; 106(2):349-357. PubMed ID: 31678224
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.